CD4 and cancer: Consistent with our results, Ouyang et al. found that an iPSC-based cancer vaccine did not induce CD4+CD25+Foxp3+ Treg infiltration into the tumor-draining lymph node (TDLN) and spleen, reversing the immunosuppressive microenvironment5.